Azadeh Elmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Azadeh Elmi has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Zhina Sadeghi
Department of Urology, Division of Reconstructive Urology University of California Irvine California USA
2 shared publications - Abdol-Mohammad Kajbafzadeh
Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
1 shared publication - Ahmad Reza Dehpour
Experimental Medicine Research Center, Tehran University of Medical Sciences
1 shared publication - Alice Chong
ICES Central, Toronto, Canada
1 shared publication Alireza Sina
Pediatric Urology Research Center, Department of Urology, Children’s Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Behtash Ghazi Nezami
Northwestern University Feinberg School of Medicine, Chicago, IL
1 shared publication
Latest Publications
- Open Access
- 3 November 2021
- Published by Springer Nature in Current Radiology Reports
- Vol. 9 (11) , 1-14
Contrast-Enhanced Mammography: Technique, Indications, and Review of Current Literature
Purpose of Review: To provide an update on contrast-enhanced mammography (CEM) regarding current technique and interpretation, the performance of this modality versus conventional breast imaging modalities (mammography, ultrasound, and MRI), existing clinical applications, potential challenges, and pitfalls. Recent Findings: Multiple studies have shown that the low-energy, non-contrast-enhanced images obtained when performing CEM are non-inferior to full-field digital mammography with the added benefit of recombined post-contrast images, which have been shown to provide comparable information compared to MRI without sacrificing sensitivity and negative predictive values. While CEMs' usefulness for further diagnostic characterization of indeterminate breast findings is apparent, additional studies have provided strong evidence of potential roles in screening intermediate to high-risk populations, evaluation of disease extent, and monitoring response to therapy, particularly in patients in whom MRI is either unavailable or contraindicated. Others have shown that some patients prefer CEM over MRI given the ease of performance and patient comfort. Additionally, some health systems may find significantly reduced costs compared to MRI. Currently, CEM is hindered by the limited availability of CEM-guided tissue sampling and issues of intravenous contrast administration. However, commercially available CEM-guided biopsy systems are on the horizon, and small changes in practice workflow can be quickly adopted. As of now, MRI remains a mainstay of high-risk screening, evaluation of the extent of disease, and monitoring response to therapy, but smaller studies have suggested that CEM may be equivalent to MRI for these indications, and larger confirmatory studies are needed. Summary: CEM is an emerging problem-solving breast imaging modality that provides complementary information to conventional imaging modalities and may potentially be used in place of MRI for specific indications and/or patient populations.
- 3 November 2021
- Published by Springer Nature in Current Radiology Reports
- Vol. 9 (11) , 1-14
Open AccessContrast-Enhanced Mammography: Technique, Indications, and Review of Current Literature
Purpose of Review: To provide an update on contrast-enhanced mammography (CEM) regarding current technique and interpretation, the performance of this modality versus conventional breast imaging modalities (mammography, ultrasound, and MRI), existing clinical applications, potential challenges, and pitfalls. Recent Findings: Multiple studies have shown that the low-energy, non-contrast-enhanced images obtained when performing CEM are non-inferior to full-field digital mammography with the added benefit of recombined post-contrast images, which have been shown to provide comparable information compared to MRI without sacrificing sensitivity and negative predictive values. While CEMs' usefulness for further diagnostic characterization of indeterminate breast findings is apparent, additional studies have provided strong evidence of potential roles in screening intermediate to high-risk populations, evaluation of disease extent, and monitoring response to therapy, particularly in patients in whom MRI is either unavailable or contraindicated. Others have shown that some patients prefer CEM over MRI given the ease of performance and patient comfort. Additionally, some health systems may find significantly reduced costs compared to MRI. Currently, CEM is hindered by the limited availability of CEM-guided tissue sampling and issues of intravenous contrast administration. However, commercially available CEM-guided biopsy systems are on the horizon, and small changes in practice workflow can be quickly adopted. As of now, MRI remains a mainstay of high-risk screening, evaluation of the extent of disease, and monitoring response to therapy, but smaller studies have suggested that CEM may be equivalent to MRI for these indications, and larger confirmatory studies are needed. Summary: CEM is an emerging problem-solving breast imaging modality that provides complementary information to conventional imaging modalities and may potentially be used in place of MRI for specific indications and/or patient populations.
- 27 May 2020
- Published by Springer Nature in Current Radiology Reports
- Vol. 8 (7) , 1-9
Calcifications on DBT and Synthetic Views: Update and Management Strategies
- 27 May 2020
- Published by Springer Nature in Current Radiology Reports
- Vol. 8 (7) , 1-9
Calcifications on DBT and Synthetic Views: Update and Management Strategies
- 1 January 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 698 (1-3) , 330-334
Na+–H+ exchange inhibition attenuates ischemic injury in rat random pattern skin flap: The role of mitochondrial ATP-sensitive potassium channels
- 1 January 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 698 (1-3) , 330-334
Na+–H+ exchange inhibition attenuates ischemic injury in rat random pattern skin flap: The role of mitochondrial ATP-sensitive potassium channels
- 29 June 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (9) , 873-878
The urethral valve of Guérin and lacuna magna: clinical presentations and urodynamic findings
We described the clinical presentations, radiological findings, urodynamic patterns and endoscopic management in a series of patients with symptomatic lacuna magna (LM). The medical records of 14 boys diagnosed as LM were reviewed, retrospectively. The presence of LM was first diagnosed based on clinical history, physical exam, and radiological findings; then confirmed by urethroscopy. Urodynamic study was performed in 10 boys before and after the procedure. Transurethral incision and fulguration of the valve was performed in all patients. The mean (range) age of patients was 3.1 years (6 months to 8 years). The boys presented with dysuria (n = 9), postvoid dribbling (n = 4), hematuria (n = 3), bloody spotting (n = 3), enuresis (n = 4), and glanular irritation and pain (n = 6). The post-operative period was uneventful in all patients. The symptoms were relieved and repeat radiological exam showed complete resolution of LM in all children by the 3rd post-surgical month. Before the procedure, main urodynamic abnormalities in children were high P detmax and detrusor instability that significantly improved within 3–6 months after treatment. Despite evidence suggesting that a LM is a frequent, normal anatomical variant, the valve may cause symptoms such as intermittent hematuria, dysuria, and bloody spotting of underwear. The lesion may be associated with obstructive urodynamic patterns in some children. Endoscopic treatment of patients effectively relieves the symptoms and corrects the urodynamic abnormalities.
- 29 June 2007
- Published by Springer Nature in Pediatric Surgery International
- Vol. 23 (9) , 873-878
The urethral valve of Guérin and lacuna magna: clinical presentations and urodynamic findings
We described the clinical presentations, radiological findings, urodynamic patterns and endoscopic management in a series of patients with symptomatic lacuna magna (LM). The medical records of 14 boys diagnosed as LM were reviewed, retrospectively. The presence of LM was first diagnosed based on clinical history, physical exam, and radiological findings; then confirmed by urethroscopy. Urodynamic study was performed in 10 boys before and after the procedure. Transurethral incision and fulguration of the valve was performed in all patients. The mean (range) age of patients was 3.1 years (6 months to 8 years). The boys presented with dysuria (n = 9), postvoid dribbling (n = 4), hematuria (n = 3), bloody spotting (n = 3), enuresis (n = 4), and glanular irritation and pain (n = 6). The post-operative period was uneventful in all patients. The symptoms were relieved and repeat radiological exam showed complete resolution of LM in all children by the 3rd post-surgical month. Before the procedure, main urodynamic abnormalities in children were high P detmax and detrusor instability that significantly improved within 3–6 months after treatment. Despite evidence suggesting that a LM is a frequent, normal anatomical variant, the valve may cause symptoms such as intermittent hematuria, dysuria, and bloody spotting of underwear. The lesion may be associated with obstructive urodynamic patterns in some children. Endoscopic treatment of patients effectively relieves the symptoms and corrects the urodynamic abnormalities.
- 1 February 2006
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 58 (2) , 277-280
Protective effects of Swertia longifolia Boiss. and its active compound, swerchirin, on paracetamol-induced hepatotoxicity in mice
Aerial parts of Swertia longifolia Boiss. (Gentianaceae), which grows in the north of Iran, were screened for hepatoprotective activity against paracetamol (acetaminophen)-induced hepatotoxicity in Swiss mice. Pretreatment with total plant extract and swerchirin, the major component of the plant, significantly reduced the elevation of biochemical parameters, AST (aspartate aminotransferase), ALT (alanine aminotransferase) and ALP (alkaline phosphatase), the enzymes that are increased by liver damage (P < 0.001). Our results indicated that total plant extract and swerchirin were hepatoprotective in the range of 6–50 mg kg−1 orally.
- 1 February 2006
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 58 (2) , 277-280
Protective effects of Swertia longifolia Boiss. and its active compound, swerchirin, on paracetamol-induced hepatotoxicity in mice
Aerial parts of Swertia longifolia Boiss. (Gentianaceae), which grows in the north of Iran, were screened for hepatoprotective activity against paracetamol (acetaminophen)-induced hepatotoxicity in Swiss mice. Pretreatment with total plant extract and swerchirin, the major component of the plant, significantly reduced the elevation of biochemical parameters, AST (aspartate aminotransferase), ALT (alanine aminotransferase) and ALP (alkaline phosphatase), the enzymes that are increased by liver damage (P < 0.001). Our results indicated that total plant extract and swerchirin were hepatoprotective in the range of 6–50 mg kg−1 orally.